Bruker: Economic Principles Indicate Dislocation To Market Expectations (NASDAQ:BRKR)

franckreporter Investment update In May this year, I published a report on Bruker Corporation (NASDAQ:BRKR), titled “Fundamental, Market Generated Data Corroborate Buy Thesis”, reiterating the company as a buy in the process. Since then, there have been multiple investment updates. Notwithstanding the travel of the broad market in H2 FY’23, BRKR itself has sold off…

Read More

Bruker’s Q2 2023 Triumph: Dominates Scientific Instrument Market Again (NASDAQ:BRKR)

Zorica Nastasic/E+ via Getty Images On August 3, 2023, Bruker Corporation (NASDAQ:BRKR), one of the leaders in the scientific instrument market, published its financial report for the second quarter of 2023. The company specializes in the design and manufacture of high-performance equipment, including for such areas as pharmaceuticals, life sciences research, and materials science research….

Read More